Sunday, June 21, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 467 of 1,261

  1. US 10441546

    Bacterially derived intact minicells that encompass plasmid free DNA and methods of using the same

    EnGeneIC Molecular Delivery Pty Ltd · Granted Oct 15, 2019 · Expires Oct 10, 2039

    granted

  2. US 10441590

    Methods for treating pulmonary hypertension

    REVIVA PHARMACEUTICALS, INC. · Granted Oct 15, 2019 · Expires Oct 10, 2039

    granted

  3. US 10441580

    Iloperidone for the treatment of schizophrenia

    VANDA PHARMACEUTICALS INC. · Granted Oct 15, 2019 · Expires Oct 10, 2039

    granted

  4. US 10441579

    4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds

    Theravance Biopharma R&D IP, LLC · Granted Oct 15, 2019 · Expires Oct 10, 2039

    granted

  5. US 10441567

    Methods and compositions for modulating hormone levels

    Ligand Pharmaceuticals Incorporated · Granted Oct 15, 2019 · Expires Oct 10, 2039

    granted

  6. US 10443076

    Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

    The Regents of the University of California · Granted Oct 15, 2019 · Expires Oct 10, 2039

    granted

  7. US 10443073

    Sin Nombre virus full-length M segment-based DNA vaccines

    The Government of the United States, as represented by the Secretary of the Army · Granted Oct 15, 2019 · Expires Oct 10, 2039

    granted

  8. US 10443049

    Active low molecular weight variants of angiotensin converting enzyme 2 (ACE2)

    Northwestern University · Granted Oct 15, 2019 · Expires Oct 10, 2039

    granted

  9. US 10442911

    Dendritic macroporous hydrogels prepared by crystal templating

    The Board of Regents of the University of Texas System · Granted Oct 15, 2019 · Expires Oct 10, 2039

    granted

  10. US 10442864

    Anti-Tie2 antibodies and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 15, 2019 · Expires Oct 10, 2039

    granted

  11. US 10442856

    Methods of treating obesity with anti-ANGPTL8 antibodies

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 15, 2019 · Expires Oct 10, 2039

    granted

  12. US 10443052

    Compositions for modulating C9ORF72 expression

    Ionis Pharmaceuticals, Inc. · Granted Oct 15, 2019 · Expires Oct 10, 2039

    granted

  13. US 10442812

    Substituted 4-methyl-pyrrolo[1,2-a]pyrimidine-8-carboxamide compounds and uses thereof for modulating glucocerebrosidase activity

    Northwestern University · Granted Oct 15, 2019 · Expires Oct 10, 2039

    granted

  14. US 10442791

    DNA-PK inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Oct 15, 2019 · Expires Oct 10, 2039

    granted

  15. US 10442784

    Compositions comprising an urolithin compound

    Amazentis SA · Granted Oct 15, 2019 · Expires Oct 10, 2039

    granted

  16. US 10442789

    Modified amino acids comprising tetrazine functional groups, methods of preparation, and methods of their use

    Sutro Biopharma, Inc. · Granted Oct 15, 2019 · Expires Oct 10, 2039

    granted

  17. US 10442759

    1-sulfonamido-4-aryloxy compounds, and preparation method and medicinal application thereof

    CHINA PHARMACEUTICAL UNIVERSITY · Granted Oct 15, 2019 · Expires Oct 10, 2039

    granted

  18. US 10442182

    In vivo live 3D printing of regenerative bone healing scaffolds for rapid fracture healing

    The Board of Regents of the University of Texas System · Granted Oct 15, 2019 · Expires Oct 10, 2039

    granted

  19. US 10441663

    Methods for treating cancer

    BicycleRD Limited · Granted Oct 15, 2019 · Expires Oct 10, 2039

    granted

  20. US 10441646

    Infectious plasmodium sporozoites grown in vitro

    Sanaria Inc. · Granted Oct 15, 2019 · Expires Oct 10, 2039

    granted

  21. US 10441677

    Methods and compositions for treating tendon degeneration

    ANIKA THERAPEUTICS, INC. · Granted Oct 15, 2019 · Expires Oct 10, 2039

    granted

  22. US 10441644

    H3.3 CTL peptides and uses thereof

    The Regents of the University of California · Granted Oct 15, 2019 · Expires Oct 10, 2039

    granted

  23. US 10441642

    Immunogenic compositions and vaccines for preventing or treating filarial disease

    The United States Government, as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 15, 2019 · Expires Oct 10, 2039

    granted

  24. US 10434075

    FKBP52 specific androgen receptor inhibitor, MJC13, for use in treating breast cancer

    The Board of Regents of the University of Texas System · Granted Oct 8, 2019 · Expires Oct 3, 2039

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.